Western Pacific Wealth Management, LP Gilead Sciences, Inc. Transaction History

Western Pacific Wealth Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $1,431 - $1,745	-20 Reduced 1.96%	1,002 $73,000
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $26,084 - $29,580	356 Added 53.45%	1,022 $82,000
Q3 2023 Oct 26, 2023	BUY	$73.94 - $80.67 $8,059 - $8,793	109 Added 19.57%	666 $49,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $40,587 - $46,242	525 Added 1640.63%	557 $46,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $1,994 - $2,863	32 New	32 $2,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Western Pacific Wealth Management, LP, based on Form 13F filings with the SEC.

Stay updated on Western Pacific Wealth Management, LP with notifications on news.